WILLIAM D. YOUNG - 26 Apr 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: Director
Signature: /s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol: TBPH
Transactions as of: 26 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 28 Apr 2022, 21:34:22 UTC
Previous filing: 09 Jun 2021
Next filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	Ordinary Shares	Award	$0	+9,852	+14%	$0.000000	78,010	26 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBPH	Share Option (Right to Buy)	Award	$0	+28,000		$0.000000	28,000	26 Apr 2022	Ordinary Shares	28,000	$10.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.